Clinical Trials Sponsored by Zeria Pharmaceutical
Total 19729 results
-
Jacobus PharmaceuticalTerminatedCrohn's DiseaseUnited States
-
BioMarin PharmaceuticalCompletedPhenylketonuriaItaly, Turkey, United Kingdom, Germany, Netherlands, Slovakia, Austria, Belgium, Czechia
-
BioMarin PharmaceuticalCompletedMorquio A Syndrome | MPS IVA | Mucopolysaccharidosis IVATaiwan, United States, Italy, United Kingdom
-
JW PharmaceuticalCompletedHypertension | HyperlipidemiaKorea, Republic of
-
Bukwang PharmaceuticalCompletedHepatitis BKorea, Republic of
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
BioMarin PharmaceuticalTerminated
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
-
BioMarin PharmaceuticalCompletedPhenylketonuriasUnited States
-
Bukwang PharmaceuticalTerminatedChronic Hepatitis BKorea, Republic of
-
BioMarin PharmaceuticalUnknownRare Genetic DisordersUnited States
-
Bukwang PharmaceuticalTerminatedChronic Hepatitis BKorea, Republic of
-
Bukwang PharmaceuticalCompletedHepatitis B Associated Hepatocellular CarcinomaKorea, Republic of
-
Bukwang PharmaceuticalCompletedHBeAg(+) Chronic Hepatitis BKorea, Republic of
-
JW PharmaceuticalCompleted
-
BioMarin PharmaceuticalTerminatedMorquio A Syndrome | MPS IV A | Mucopolysaccharidosis IVAFrance, United Kingdom, Taiwan, United States, Argentina, Netherlands, Canada, Brazil, Germany, Italy
-
Effexus PharmaceuticalUnknownBarrett's EsophagusUnited States
-
JW PharmaceuticalCompletedChronic Renal Failure | AnaemiaKorea, Republic of
-
JW PharmaceuticalCompletedHypertension | DyslipidemiaKorea, Republic of
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
Chugai PharmaceuticalCompletedAdvanced or Metastatic HCCUnited States
-
Bukwang PharmaceuticalTerminatedHepatitis BKorea, Republic of
-
JW PharmaceuticalCompletedNeurogenic Bladder | Voiding DysfunctionKorea, Republic of
-
Bukwang PharmaceuticalCompleted
-
Chugai PharmaceuticalCompleted
-
Bukwang PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedAchondroplasiaUnited States
-
Chugai PharmaceuticalCompleted
-
Bukwang PharmaceuticalCompletedDiabetic NeuropathiesKorea, Republic of
-
JW PharmaceuticalCompletedBenign Prostatic HypertrophyKorea, Republic of
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VI | Maroteaux-Lamy SyndromeUnited States, Portugal, France
-
Bukwang PharmaceuticalCompletedHepatitis BKorea, Republic of
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan
-
Chugai PharmaceuticalCompletedLiver Cirrhosis | Chronic Hepatitis CJapan
-
JW PharmaceuticalCompletedErectile DysfunctionKorea, Republic of
-
BioMarin PharmaceuticalCompleted
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
Chugai PharmaceuticalCompletedPolyarticular Juvenile Idiopathic Arthritis
-
Chugai PharmaceuticalCompletedSystemic Juvenile Idiopathic Arthritis
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States
-
Chugai PharmaceuticalCompletedRheumatoid Arthritis
-
Chugai PharmaceuticalCompletedSystemic Juvenile Idiopathic Arthritis
-
Chugai PharmaceuticalCompletedSystemic Juvenile Idiopathic Arthritis
-
Lotus PharmaceuticalCompletedMigraine Without Aura | Migraine With AuraTaiwan
-
Jacobus PharmaceuticalTerminatedPemphigus VulgarisUnited States
-
BioMarin PharmaceuticalCompletedMucopolysaccharidosis VIUnited States